| Dr Daniel James Kohler, DPH | |
|
2467 Nazareth Rd, Easton, PA 18045-2743 | |
| (610) 258-3961 | |
| Not Available |
| Full Name | Dr Daniel James Kohler |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2467 Nazareth Rd, Easton, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013179035 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP441978 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel James Kohler, DPH 240 7th Ave, Apt. 2, Bethlehem, PA 18018-5128 Ph: (610) 653-0432 | Dr Daniel James Kohler, DPH 2467 Nazareth Rd, Easton, PA 18045-2743 Ph: (610) 258-3961 |
News Archive
A Ludwig Cancer Research study has identified a previously unrecognized mechanism by which cancer cells of a relatively benign subtype of pancreatic tumors methodically revert-or "de-differentiate"-to a progenitor, or immature, state of cellular development to spawn highly aggressive tumors that are capable of metastasis to the liver and lymph nodes.
Cyanobacteria are among the most primitive living beings, aged over 3,500 million years old. These aquatic microorganisms helped to oxygenate the earth-atmosphere. At present their populations are increasing in size without stopping. It appears that global warming may be behind the rise in their numbers and may also lead toan increase in the amount of toxins produced by some of these populations.
Omega Healthcare Investors, Inc. today announced its results of operations for the quarter ended June 30, 2010. The Company also reported Funds From Operations ("FFO") available to common stockholders for the three months ended June 30, 2010 of $29.7 million or $0.32 per common share.
D3 Oncology Solutions today announced that it will provide its Via Oncology Pathways for a six-month free trial period to enable cancer programs to align the timing of their investment with a strategy for sharing potential savings with payors and other key stakeholders.
A preprint discusses the results of a study of antibody responses to the first and second dose of currently available SARS-CoV-2 vaccines, Pfizer and Oxford.
› Verified 9 days ago
Sharon Horvath, RPH, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Northampton St, Easton, PA 18042 Phone: 610-868-6116 | |
Meredith Miranda, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3835 Dryland Way, Easton, PA 18045 Phone: 610-250-5281 | |
Joelle Nadine Harmonosky, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Town Center Blvd, Easton, PA 18040 Phone: 610-559-1209 Fax: 844-411-6799 | |
Shawn Thomas Lynn, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 215 Town Center Blvd, Easton, PA 18040 Phone: 610-250-3651 | |
Samantha Rosenberg, CPHT Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3825 Sullivan Trl, Easton, PA 18040 Phone: 610-252-6756 | |
Mr. Michael Dennis Tercha, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 282 Line St, Easton, PA 18042 Phone: 610-515-9170 |